Literature DB >> 23097135

Early SAPIEN transcatheter heart valve dysfunction due to tissue ingrowth in an octogenarian.

J Blumenstein, A Van Linden, W K Kim, W Skwara, M Schoenburg, M Arsalan, H Moellmann, M Niederhagen, J Kempfert, T Walther.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23097135     DOI: 10.1007/s00392-012-0518-1

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  7 in total

Review 1.  Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature.

Authors:  L Figulla; A Neumann; H R Figulla; P Kahlert; R Erbel; T Neumann
Journal:  Clin Res Cardiol       Date:  2010-12-17       Impact factor: 5.460

2.  Transapical aortic valve implantation: mid-term outcome from the SOURCE registry.

Authors:  Olaf Wendler; Thomas Walther; Holger Schroefel; Rüdiger Lange; Hendrik Treede; Melissa Fusari; Paolo Rubino; Martyn Thomas
Journal:  Eur J Cardiothorac Surg       Date:  2012-05-30       Impact factor: 4.191

3.  Cardiac surgery in Germany during 2010: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery.

Authors:  J F Gummert; A K Funkat; A Beckmann; M Ernst; K Hekmat; F Beyersdorf; W Schiller
Journal:  Thorac Cardiovasc Surg       Date:  2011-06-10       Impact factor: 1.827

4.  One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.

Authors:  Martyn Thomas; Gerhard Schymik; Thomas Walther; Dominique Himbert; Thierry Lefèvre; Hendrik Treede; Holger Eggebrecht; Paolo Rubino; Antonio Colombo; Rüdiger Lange; Rebecca R Schwarz; Olaf Wendler
Journal:  Circulation       Date:  2011-07-11       Impact factor: 29.690

5.  PREVAIL TRANSAPICAL: multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II).

Authors:  Thomas Walther; Matthias Thielmann; Joerg Kempfert; Holger Schroefel; Gerhard Wimmer-Greinecker; Hendrik Treede; Thorsten Wahlers; Olaf Wendler
Journal:  Eur J Cardiothorac Surg       Date:  2012-01-30       Impact factor: 4.191

6.  Crimping may affect the durability of transcatheter valves: an experimental analysis.

Authors:  Philipp Kiefer; Felix Gruenwald; Joerg Kempfert; Heike Aupperle; Joerg Seeburger; Friedrich Wilhelm Mohr; Thomas Walther
Journal:  Ann Thorac Surg       Date:  2011-07       Impact factor: 4.330

7.  Insufficiency of an aortic valve prosthesis due to tissue ingrowth: a case report.

Authors:  Stefan Christiansen; Wolfgang Fehske; Rüdiger Autschbach
Journal:  Heart Surg Forum       Date:  2007       Impact factor: 0.676

  7 in total
  4 in total

1.  Safety and efficacy of the subclavian access route for TAVI in cases of missing transfemoral access.

Authors:  Andrea Muensterer; Domenico Mazzitelli; Hendrik Ruge; Anke Wagner; Ina Hettich; Nicolo Piazza; Ruediger Lange; Sabine Bleiziffer
Journal:  Clin Res Cardiol       Date:  2013-05-11       Impact factor: 5.460

Review 2.  Worldwide TAVI registries: what have we learned?

Authors:  Stephan Haussig; Gerhard Schuler; Axel Linke
Journal:  Clin Res Cardiol       Date:  2014-03-20       Impact factor: 5.460

3.  Transcatheter mitral valve replacement: tissue in-growth after 4 weeks.

Authors:  Georg Lutter; Lennart Bax; Yazhou Liu; Jan-Hinnerk Hansen; Derk Frank; Sandra Freitag-Wolf; Agneta Simionescu; Janarthanan Sathananthan; Thomas Puehler
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-01

4.  Can postoperative mean transprosthetic pressure gradient predict survival after aortic valve replacement?

Authors:  Bart M Koene; Mohamed A Soliman Hamad; Wobbe Bouma; Massimo A Mariani; Kathinka C Peels; Jan-Melle van Dantzig; Albert H van Straten
Journal:  Clin Res Cardiol       Date:  2013-10-18       Impact factor: 5.460

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.